Using Microfluidic Separation Sperm Selection for Unexplained Infertility and Reccurrent Implantation Failure
Unexplained Infertility, Recurrent Implantation Failure
About this trial
This is an interventional screening trial for Unexplained Infertility focused on measuring unexplained infertility, recurrent implantation failure
Eligibility Criteria
Unexplained Infertility Group; The inclusion criteria are;
- normal HSG,
- normal hormone levels,
- normal over functions,
- having normal uterine cavity and endometrial thickness determined by office hysteroscopy
- no endometriosis (determined by transvaginal ultrasonography and / or diagnostic laparoscopy)
- normal spermiogram result Recurrent Implantation Failure The inclusion criteria are;
1-The inclusion criteria of the working group are: 2-Failure of embryo transfer at least twice after high quality embryo transfer after 3-IVF treatment, 4-having normal hormone reserve (FSH <8 mIU / mL), 5-respond well to hormone stimulation (> 8 oocyte collection), 6-having normal uterine cavity and endometrial thickness determined by office hysteroscopy
Sites / Locations
- Acibadem Fulya Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Experimental
Active Comparator
Experimental
UEI Sperm Chip (-)
UEI Sperm Chip (+)
RIF sperm chip (-)
RIF sperm chip (+)
Conventional IVF treatment and using conventional sperm selection
Conventional IVF treatment and using sperm chip for sperm selection
Conventional IVF treatment and using conventional sperm selection
Conventional IVF treatment and using sperm chip for sperm selection